Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug Monitoring

Further Publications Rheumatology

Cost-effectiveness of risk-stratified blood-test monitoring strategies for adults with inflammatory conditions

Rheumatology (Oxford)

Stevenson M, Nakafero G, Williams HC, Card T, Taal MW, Aithal GP, Fox CP, Abhishek A

doi: 10.1093/rheumatology/keaf623

Systemic Lupus Erythematosus

Temporal trends in glucocorticoids and hydroxychloroquine for treatment of systemic lupus erythematosus in Sweden

Rheumatology (Oxford)

Dominicus A, Mageau A, Nguyen NV, Blomkvist Sporre K, Svenungsson E, Arkema EV

doi: 10.1093/rheumatology/keaf192

Rheumatoid Arthritis

Identifying resolution of clinically suspect arthralgia: a step towards understanding spontaneous reversal of an at-risk stage of rheumatoid arthritis

J Rheumatol

Khidir SJH, van Mulligen E, van der Helm-van Mil AHM

doi: 10.3899/jrheum.2025-0052

Autoimmune Disease

The development of a risk threshold to aid risk stratified approach to monitoring for haematological, hepatic and/or renal adverse drug reactions during established conventional synthetic DMARD treatment for systemic autoimmune rheumatic diseases: a RAND/UCLA Appropriateness Method consensus study

Rheumatology (Oxford)

Ablewhite J, Nakafero G, Almayahi A, Bechman K, Ahmed A, Davidson A, De Vere H, Dhillon E, Foulkes A, Gullick N, Heaton R, Hider S, Kyle S, Nowak K, Rose-Parfitt E, Ryan S, Tan SY, Wood N, Zebate G, Parsons K, Holmes J, Twohigg H, Reynolds JA, Mercer L, Galloway J, Abhishek A

doi: 10.1093/rheumatology/keag031

Systemic Lupus Erythematosus

Effects of sodium-glucose transporter 2 inhibitors in patients with lupus nephritis: a before-and-after retrospective cohort study

Rheumatology (Oxford)

Ramírez-Mulhern I, Navarro-Sánchez V, Rivero-Otamendi E, Sánchez-Mejía DE, Zavala-Miranda MF, Mejia-Vilet JM

doi: 10.1093/rheumatology/keaf548

Rheumatoid Arthritis

Baseline interleukin-10 levels as a predictive biomarker for achieving clinical response with abatacept in disease-modifying antirheumatic drug-naive and anticitrullinated protein antibody-positive patients with early rheumatoid arthritis

Arthritis Rheumatol

Liu J, Li Y, Fu K, Wu C, Schafer P, Connolly SE, Catlett IM, Maldonado MA, Wong R, Emery P, Tanaka Y, Bykerk VP, Bingham CO, Huizinga TWJ, Fleischmann R

doi: 10.1002/art.70106

Osteoarthritis

Effects of Blood-Flow Restricted Resistance Exercise Versus Neuromuscular Exercise on Self-Perceived Knee Pain, Function, Quality of Life, and Objective Measures of Functional Performance and Pain Sensitization in Adults With Knee Osteoarthritis-A Randomized Controlled Trial

Scand J Med Sci Sports

Sørensen B, Magnusson SP, Aagaard P, Svensson RB, Hjortshoej MH, Hansen SK, Suetta C, Couppé C, Johannsen FE

doi: 10.1111/sms.70154

Acne

Safe and Effective Acne Treatment Across Skin Types with a 1726 nm Sebum-Selective Laser: One Year Data from a Prospective Multicenter Study

J Am Acad Dermatol

Goldberg D, Ronan S, Bhatia A, Dhawan SS, Green JB, Kilmer SL, Kwan W, Stein Gold L, Weiss JS, Doucette M, Karavitis M, Dover JS

doi: 10.1016/j.jaad.2025.09.077

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Related content

Cost-effectiveness of risk-stratified blood-test monitoring strategies for adults with inflammatory conditions

Temporal trends in glucocorticoids and hydroxychloroquine for treatment of systemic lupus erythematosus in Sweden

Identifying resolution of clinically suspect arthralgia: a step towards understanding spontaneous reversal of an at-risk stage of rheumatoid arthritis

The development of a risk threshold to aid risk stratified approach to monitoring for haematological, hepatic and/or renal adverse drug reactions during established conventional synthetic DMARD treatment for systemic autoimmune rheumatic diseases: a RAND/UCLA Appropriateness Method consensus study

Effects of sodium-glucose transporter 2 inhibitors in patients with lupus nephritis: a before-and-after retrospective cohort study

Baseline interleukin-10 levels as a predictive biomarker for achieving clinical response with abatacept in disease-modifying antirheumatic drug-naive and anticitrullinated protein antibody-positive patients with early rheumatoid arthritis

Effects of Blood-Flow Restricted Resistance Exercise Versus Neuromuscular Exercise on Self-Perceived Knee Pain, Function, Quality of Life, and Objective Measures of Functional Performance and Pain Sensitization in Adults With Knee Osteoarthritis-A Randomized Controlled Trial

Safe and Effective Acne Treatment Across Skin Types with a 1726 nm Sebum-Selective Laser: One Year Data from a Prospective Multicenter Study

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state